CBU
IMRX icon

CIBC Bancorp USA’s Immuneering IMRX Stock Holding History

CIBC Bancorp USA’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Buy
24,460
+960
+4% +$4.86K ﹤0.01% 1838
2026
Q1 		$124K Buy
+23,500
New +$120K ﹤0.01% 1668

Other funds holding IMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

CIBC Bancorp USA's IMRX Position: Q2 2026 in Review

CIBC Bancorp USA increased its Immuneering (IMRX) stake by 4.1% in Q2 2026, buying an estimated $4.86K and bringing the position to 24,460 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

CIBC Bancorp USA first reported a position in IMRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $124K in Q1 2026. 103 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • CIBC Bancorp USA held 24,460 shares of Immuneering worth $122K as of Q2 2026.
  • CIBC Bancorp USA bought 960 Immuneering shares in Q2 2026, an estimated $4.86K.
  • Immuneering made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1838 holding.
  • CIBC Bancorp USA first reported a position in Immuneering in Q1 2026 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Immuneering position peaked at $124K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.